Neurocritical Care
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines
for the early management of patients with acute isch-
emic stroke: 2019 update to the 2018 guidelines for the
early management of acute ischemic stroke: a guide-
line for healthcare professionals from the American
Heart
Association/American
Stroke
Association.
Stroke. 2019;50(12):e344-e418. https://doi.org/10.1161/
str.0000000000000211
Qureshi AI, Palesch YY, Barsan WG, et al. Intensive
blood-pressure lowering in patients with acute cerebral
hemorrhage. N Engl J Med. 2016;375(11):1033-1043.
https://doi.org/10.1056/nejmoa1603460
Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of
hypertonic (3%) saline/acetate infusion in the treat-
ment of cerebral edema: effect on intracranial
pressure and lateral displacement of the brain. Crit
Care
Med.
1998;26(3):440-446.
https://doi.
org/10.1097/00003246-199803000-00011
Rabinstein AA, Benarroch EE. Treatment of parox-
ysmal sympathetic hyperactivity. Curr Treat Options
Neurol.
2008;10(2):151-157.
https://doi.org/10.1007/
s11940-008-0016-y
Reshetnyak E, Ntamatungiro M, Pinheiro LC, et al.
Impact of multiple social determinants of health on inci-
dent stroke. Stroke. 2020;51(8):2445-2453. https://doi.
org/10.1161/strokeaha.120.028530
Rhoney DH, Parker D Jr. Considerations in fluids and
electrolytes after traumatic brain injury. Nutr Clin Pract.
2006;21(5):462-478. https://doi.org/10.1177/0115426506
Robba C, Pozzebon S, Moro B, Vincent JL, Creteur
J, Taccone FS. Multimodal non-invasive assess-
ment of intracranial hypertension: an observational
s13054-020-03105-z
Roberts I, Yates D, Sandercock P, et al. Effect of intra-
venous corticosteroids on death within 14 days in
10008 adults with clinically significant head injury
(MRC CRASH trial): randomised placebo-controlled
org/10.1016/s0140-6736(04)17188-2
Robertson CS, Valadka AB, Hannay HJ, et al. Prevention
of secondary ischemic insults after severe head
doi.org/10.1097/00003246-199910000-00002
Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P,
Wolf S. Nimodipine dose reductions in the treatment
of patients with aneurysmal subarachnoid hemor-
rhage. Neurocrit Care. 2016;25(1):29-39. https://doi.
org/10.1007/s12028-015-0230-x
Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and
safety of a 4-factor prothrombin complex concentrate in
patients on vitamin K antagonists presenting with major
bleeding: a randomized, plasma-controlled, phase IIIb
study. Circulation. 2013;128(11):1234-1243. https://doi.
org/10.1161/circulationaha.113.002283
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever
thrombectomy after intravenous t-PA vs. t-PA alone in
stroke. N Engl J Med. 2015;372(24):2285-2295. https://
doi.org/10.1056/nejmoa1415061
Schwartz ML, Tator CH, Rowed DW, Reid SR,
Meguro K, Andrews DF. The University of Toronto
head injury treatment study: a prospective, random-
ized comparison of pentobarbital and mannitol. Can J
Neurol Sci. 1984;11(4):434-440. https://doi.org/10.1017/
s0317167100045960
Seder DB, Schmidt JM, Badjatia N, et al. Transdermal
nicotine replacement therapy in cigarette smok-
ers with acute subarachnoid hemorrhage. Neurocrit
Care.
2011;14(1):77-83.
https://doi.org/10.1007/
s12028-010-9456-9
Silbergleit
R,
Durkalski
V,
Lowenstein
D,
et
al.
Intramuscular
versus
intravenous
ther-
apy for prehospital status epilepticus. N Engl
J Med. 2012;366(7):591-600. https://doi.org/10.1056/
nejmoa1107494
Smetana KS, Buschur PL, Owusu-Guha J, May CC.
Pharmacologic management of cerebral vasospasm
Nurs Q. 2020;43(2):138-156. https://doi.org/10.1097/
cnq.0000000000000299
Spasovski G, Vanholder R, Allolio B, et al. Clinical
practice guideline on diagnosis and treatment of
331. https://doi.org/10.1007/s00134-014-3210-2
Taylor SJ, Fettes SB, Jewkes C, Nelson RJ. Prospective,
randomized, controlled trial to determine the effect of
early enhanced enteral nutrition on clinical outcome
in mechanically ventilated patients suffering head
doi.org/10.1097/00003246-199911000-00033